<DOC>
	<DOCNO>NCT03103958</DOCNO>
	<brief_summary>The probiotic oral use , ProbiatopÂ® , consist Lactobacillus acidophilus NCFM , Lactobacillus rhamnosus HN001 , Lactobacillus paracasei LPC-37 Bifidobacterium lactis HN019 . Its activity compare placebo ( Maltodextrin ) . The metagenomics data correlate Quality Life Questionnaire answer obtain participant intestinal transit problem . The Increase number evacuation , well improvement complaint related intestinal transit alteration evaluate study . The participant use probiotic placebo period 28 day gastrointestinal function questionnaire collect stool perform study period treatment</brief_summary>
	<brief_title>Effects Probiotic Modulation Intestinal Microbiota Constipated Patients</brief_title>
	<detailed_description>It double-blind , randomize , placebo control study evaluate action probiotic relation placebo human intestinal microbiome technique metagenomics , well evaluated effect probiotic gastrointestinal transit constipate participant . One hundred twenty constipate patient randomize two group : Probiatop Placebo . The first 22 patient group also perform metagenomic evaluation stool sample collection treatment . Besides procedure , patient fill symptom assessment questionnaire baseline study , 14 28 day begin treatment .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Dysbiosis</mesh_term>
	<criteria>Agree adhere procedures requirement study attend institute day ( ) time ( ) determine evaluation ; Being able consent study participation Have one complaint change bowel habit last 3 month onset symptom least 6 month diagnosis , describe : Evacuation effort least 25 % defecation Lumpy stool , sausageshaped harden least 25 % stool , accord Bristol scale . number 1 , 2 3 ; Incomplete evacuation count least 25 % defecation ; Feeling anorectal obstruction / blockage feces least 25 % defecation ; Manufactured manual facilitate least 25 % stool ( example , evacuation digital help , pelvic floor support ) Pregnancy breastfeeding ; Known intolerance allergy study product ; Previous history gastrointestinal surgery ; Patients celiac disease inflammatory bowel disease ; Patients psychiatric , cardiologic , respiratory , renal hepatic disease ; No acceptance study admission participant ; Diagnosis Clostridium difficile diarrhea last 3 month ; Patients know immunosuppressive disease ; Any gastrointestinal pathology ; Prior use antibiotic less 30 day ; Frequent use laxatives medication alters bowel motility ( one week without Use inclusion ) Regular treatment probiotic / symbiotic , include regular use yogurt probiotic ( One week use inclusion ) Regular use antidepressant , opioid analgesic , antispasmodic anticholinergic agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>probiotic</keyword>
	<keyword>metagenomic</keyword>
	<keyword>constipation</keyword>
</DOC>